hermo Fisher Scientific announces the availability of the Thermo Scientific AcroMetrix Coronavirus 2019 (COVID-19) RNA Control, its latest quality control product to monitor and validate COVID-19 molecular diagnostic tests.
The National Institutes of Health (NIH) is our nation’s medical research agency and strives to make scientific discoveries that improve health and save lives. Founded in 1870, the NIH conducts its own scientific research through its Intramural Research Program (IRP), which supports approximately 1,200 principal investigators and more than 4,000 postdoctoral fellows conducting basic, translational and clinical research. In this blog, we will highlight recent ground-breaking NIH research.
You can’t escape the knowledge that the world is currently in the midst of a global pandemic of COVID-19, the disease caused by the novel SARS-CoV-2 strain of coronavirus. Tracking and slowing the spread of disease have been on everyone’s mind for much of the year. We know that this will be difficult to do without rapid and accurate testing, which has been in short supply in the United States. The U.S. must produce or acquire accurate tests, quickly and in high volumes, which is why many are pushing to loosen regulations to get more tests into the hands of health care professionals. The laboratory informatics experts at CSols have a unique insight into laboratory testing and data analysis, and we have been discussing—remotely, of course—how our experience with successful LIMS implementations can help experts predict and prevent future pandemics.
Like it or not, physician or not, the current pandemic is already affecting you in some ways or others. And those physicians on the front line seeing patients cannot avoid being involved. If you have testing equipment of your own, at least you may be able to recoup some of the costs of seeing potential COVID-19 patients, handling specimens and meeting reporting requirements.
ATLANTA – LabLynx, Inc., long-time leader in enterprise-level cloud-hosted LIMS/LIS, today announced it has developed the world’s first LIMS (Laboratory Information Management System) dedicated specifically to COVID-19 diagnostic testing. Called "CovidLIMS”, its main features include, crucially, swift setup-to-live time: 2-5 days, including training, according to LabLynx President John H. Jones.
In this March 2020 journal article published in the journal Micromachines, Nguyen, Bang, and Wolff give their professional take on point-of-care diagnostics for combating the COVID-19 epidemic. In particular, the authors discuss the loop-mediated isothermal amplification (LAMP) nucleic acid amplification technique and its potential to make COVID-19 testing faster, more portable, more flexible, more stable, and more sensitive. After discussing the then-recent events (information is changing rapidly), the authors compare real-time reverse transcription polymerase chain reaction (rRT-PCR) with LAMP methods and discuss other important factors affecting society because of the pandemic.